Evidence map›Paper›PMID 33557205›Full record

ArticleCells2021

A Transcription Regulatory Sequence in the 5' Untranslated Region of SARS-CoV-2 Is Vital for Virus Replication with an Altered Evolutionary Pattern against Human Inhibitory MicroRNAs.

Manijeh Mohammadi-Dehcheshmeh, Sadrollah Molaei Moghbeli, Samira Rahimirad, Ibrahim O Alanazi, Zafer Saad Al Shehri, Esmaeil Ebrahimie

Open access · goldAbstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 4 countries.

Manijeh Mohammadi-DehcheshmehLa Trobe Genomics Research Platform, School of Life Sciences, College of Science, Health and Engineering, La Trobe University, Melbourne, VIC 3086, Australia.
Sadrollah Molaei MoghbeliDepartment of Animal Science, College of Agricultural and Life Sciences, University of Wisconsin, Madison, WI 1675, USA.
Samira RahimiradDepartment of Medical Genetics, National Institute of Genetic Engineering and Biotechnology, Tehran 1497716316, Iran.ORCID 0000-0002-1997-7327
Ibrahim O AlanaziNational Center for Biotechnology, Life Science and Environment Research Institute, King Abdulaziz City for Science and Technology (KACST), Riyadh 6086, Saudi Arabia.
Zafer Saad Al ShehriDepartment of Medical Laboratories, College of Applied Medical Sciences, Shaqra University, KSA, Al dawadmi 1678, Saudi Arabia.
Esmaeil EbrahimieLa Trobe Genomics Research Platform, School of Life Sciences, College of Science, Health and Engineering, La Trobe University, Melbourne, VIC 3086, Australia.
King Abdulaziz City for Science and Technology · SALa Trobe University · AUNational Institute of Genetic Engineering and Biotechnology · IRShaqra University · SAThe University of Melbourne · AUUniversity of Wisconsin–Madison · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our knowledge of the evolution and the role of untranslated region (UTR) in SARS-CoV-2 pathogenicity is very limited. Leader sequence, originated from UTR, is found at the 5' ends of all encoded SARS-CoV-2 transcripts, highlighting its importance. Here, evolution of leader sequence was compared between human pathogenic and non-pathogenic coronaviruses. Then, profiling of microRNAs that can inactivate the key UTR regions of coronaviruses was carried out. A distinguished pattern of evolution in leader sequence of SARS-CoV-2 was found. Mining all available microRNA families against leader sequences of coronaviruses resulted in discovery of 39 microRNAs with a stable thermodynamic binding energy. Notably, SARS-CoV-2 had a lower binding stability against microRNAs. hsa-MIR-5004-3p was the only human microRNA able to target the leader sequence of SARS and to a lesser extent, also SARS-CoV-2. However, its binding stability decreased remarkably in SARS-COV-2. We found some plant microRNAs with low and stable binding energy against SARS-COV-2. Meta-analysis documented a significant (

Indexed as

5' Untranslated RegionsVirus ReplicationAnimalsComputational BiologyCOVID-19Evolution, MolecularGenome, ViralHumansMicroRNAsNucleic Acid ConformationRNA, PlantSARS-CoV-25' Untranslated RegionsMicroRNAsRNA, PlantbiomarkerCOVID-19drug repurposingmicroRNAmicroRNA vaccinenanoparticle vaccineSARS-CoV-2 replicationvariant discovery

Identifiers

PMID33557205
PMCPMC7913991
OpenAlexW3127718849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.